XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Revenue:    
Total revenue $ 22,297 $ 22,616
Operating costs and expenses:    
Type of Cost, Good or Service [Extensible List] us-gaap:ProductMember us-gaap:ProductMember
Product costs $ 3,743 $ 3,203
Research and development 10,882 12,142
Selling, general and administrative 7,023 6,943
Acquired intangible asset amortization 556 594
Total operating costs and expenses 22,204 22,882
Operating income (loss) 93 (266)
Other (expense) income:    
Investment income, net 41 250
Interest expense (60) (40)
Foreign exchange loss (180) (47)
Other   1
Other (expense) income (199) 164
Loss before income taxes (106) (102)
Income tax (provision) benefit (168) 250
Net (loss) income $ (274) $ 148
Basic net (loss) income per share $ (0.02) $ 0.01
Diluted net (loss) income per share $ (0.02) $ 0.01
Weighted average number of shares outstanding:    
Basic 13,668 13,469
Diluted 13,668 13,769
Product Sales [Member]    
Revenue:    
Total revenue $ 10,102 $ 9,974
Royalties and License Fees [Member]    
Revenue:    
Total revenue 9,334 10,148
Research, Development and Other [Member]    
Revenue:    
Total revenue $ 2,861 $ 2,494